Their mechanism of action consists in lifting the immune inhibition generated by tumor cells on key elements of the immune cascade, such as PD-1 (programmed cell death 1) and CTLA-4 (cytotoxic T-lymphocyte antigen 4) located on the immune cells. Here, PDCD1 is linked to neoplasm.